Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Genentech Singapore Biologics Plant

Project Type

Merger of two large-scale bulk biologics manufacturing plants

FDA Licensure Status

Expected in 2010

Capacity

<i>E coli</i> facility – 1,000l<br />Genentech manufacturing facility – 80,000l

Output

<i>E coli</i> facility – Lucentis<br /> Genentech manufacture facility – Avastin (bevacizumab) and Herceptin

Go Top